ICAM3 |
ICAM3: Intercellular adhesion molecule 3 precursor |
PRKCQ |
PRKCQ, PRKCT: Protein kinase C theta type |
2.94 |
Evidence |
|
MGMT |
MGMT: Methylated-DNA--protein-cysteine methyltransferase |
SH2D2A |
SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A |
2.94 |
Evidence |
|
PRSS22 |
PRSS22, BSSP4, SP001LA, PRSS26, UNQ302/PRO343: Brain-specific serine protease 4 |
CORT |
CORT, UNQ307/PRO350: Cortistatin precursor [Contains: Cortistatin-29; Cortistati |
2.94 |
Evidence |
|
ERBB2 |
ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor |
DSG2 |
DSG2: Desmoglein-2 precursor |
2.94 |
Evidence |
|
H3F3A |
H3F3A, H3.3A, PP781, H3.3B, H3F3B, H3F3: Histone H3.3 |
E2F1 |
E2F1, RBBP3: Transcription factor E2F1 |
2.94 |
Evidence |
|
CP |
CP: Ceruloplasmin precursor |
SERPING1 |
SERPING1, C1IN, C1NH: Plasma protease C1 inhibitor precursor |
2.94 |
Evidence |
|
CASP3 |
CASP3, CPP32: Caspase-3 precursor |
CASP8 |
IPI00305242 |
2.94 |
Evidence |
|
POLR2A |
POLR2A: Uncharacterized protein POLR2A |
VCPIP1 |
VCPIP1, KIAA1850, VCIP135: Deubiquitinating protein VCIP135 |
2.94 |
Evidence |
|
SLA |
SLA, SLAP, SLAP1: SRC-like-adapter |
VAV2 |
VAV2, RP11-153P4.1-003: Vav 2 oncogene |
2.94 |
Evidence |
|
BCL2 |
BCL2: Apoptosis regulator Bcl-2 |
PRKAR1A |
PRKAR1A, PKR1, PRKAR1, TSE1: cAMP-dependent protein kinase type I-alpha regulato |
2.94 |
Evidence |
|
PABPC4 |
PABPC4, APP1, PABP4: Polyadenylate-binding protein 4 |
NEK1 |
NEK1, KIAA1901: Serine/threonine-protein kinase Nek1 |
2.94 |
Evidence |
|
APOH |
APOH, B2G1: Beta-2-glycoprotein 1 precursor |
EDN2 |
EDN2: Endothelin-2 precursor |
2.94 |
Evidence |
|
CARS |
CARS: Cysteinyl-tRNA synthetase, cytoplasmic |
SLA |
SLA, SLAP, SLAP1: SRC-like-adapter |
2.94 |
Evidence |
|
PER2 |
PER2, KIAA0347: Period circadian protein homolog 2 |
PABPN1 |
PABPN1, PAB2, PABP2: Polyadenylate-binding protein 2 |
2.94 |
Evidence |
|
COIL |
COIL, CLN80: Coilin |
CDC6 |
CDC6, CDC18L: Cell division control protein 6 homolog |
2.94 |
Evidence |
|
JUND |
JUND: Transcription factor jun-D |
STRN3 |
STRN3, GS2NA, SG2NA: Striatin-3 |
2.94 |
Evidence |
|
SH2D2A |
SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A |
AHNAK |
AHNAK: AHNAK protein |
2.94 |
Evidence |
|
EDN1 |
EDN1: Endothelin-1 precursor |
EDN2 |
EDN2: Endothelin-2 precursor |
2.94 |
Evidence |
|
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
ZYX |
ZYX: Zyxin |
2.94 |
Evidence |
|
AGT |
AGT, SERPINA8: Angiotensinogen precursor |
EDN2 |
EDN2: Endothelin-2 precursor |
2.94 |
Evidence |
|
SYK |
SYK: Tyrosine-protein kinase SYK |
RANGAP1 |
RANGAP1, SD: Ran GTPase-activating protein 1 |
2.94 |
Evidence |
|
POLR2A |
POLR2A: Uncharacterized protein POLR2A |
NCOA3 |
IPI00220082 |
2.94 |
Evidence |
|
F5 |
F5: Coagulation factor V precursor |
PRG2 |
PRG2, MBP: Bone marrow proteoglycan precursor |
2.94 |
Evidence |
|
LTB4R |
LTB4R, BLT, BLT1, BLTR, CMKRL1, GPR16, P2RY7: Leukotriene B4 receptor 1 |
HBEGF |
HBEGF, DTR, DTS, HEGFL: Proheparin-binding EGF-like growth factor precursor [Con |
2.94 |
Evidence |
|
TF |
TF, PRO1400: Serotransferrin precursor |
CFI |
CFI, IF: Complement factor I precursor |
2.94 |
Evidence |
|